Radiotherapy developer Eckert & Ziegler said it has begun construction of a new cyclotron facility to manufacture PET radiopharmaceuticals in Warsaw.
The firm will spend approximately 7 million euros ($9.3 million U.S.) to start up its cyclotron to produce FDG, and the large facility will include laboratories for research and development of new radiodiagnostic agents, the company said.
Once construction is complete, the company will supply F-18 FDG and other radiotracers for cancer imaging diagnostics from this plant to nuclear medical facilities in Warsaw and the central and eastern regions of Poland.
The Warsaw location was chosen due to the availability of a highly skilled labor force and the large number of nuclear facilities in the region, as well as transportation facilities that enable the fast delivery of radiopharmaceuticals to cancer centers, Eckert & Ziegler said.
